Purchase Order 75N92E26P00008
- Not listed
- This is a firm fixed-price delivery order contract awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) through the Multiple Award Schedule (MAS) contract vehicle. The $34,044.12 contract provides for the continued maintenance, technical support, preventative maintenance, parts, and software revisions for BD's flow cytometry instruments used by NHGRI. As the sole provider of parts,...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Human Genome Research Institute awarded a $34,044.12 delivery order contract to Becton, Dickinson and Company (BD) for the provision of continued maintenance, technical support, preventative maintenance, parts, and software revisions for flow cytometers. The contract is not set aside and is under BD's existing Multiple Award Schedule (MAS) contract with the General Services Administration. BD is a...
- This federal contract award, valued at $29,602.48, was made by the National Human Genome Research Institute (part of the National Institutes of Health) to Becton, Dickinson and Company (BD), a global medical technology company. The contract is for the delivery of a FACS Aria Special SN P22300063 flow cytometry system and associated services. BD Biosciences, a division of BD, is the prime contractor. The contract is a firm fixed-price Delivery Order and does not have a set-aside designation. BD...
- This contract award to Becton, Dickinson and Company (BD), a global medical technology company, is for a Firm Fixed Price Delivery Order valued at $23,180.04. It is being issued by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), a civilian federal agency. The award is for a one-year service agreement on a FACS Aria flow cytometer, a specialized instrument used in biomedical research and clinical applications. BD, through its BD...
- This is a firm-fixed price delivery order contract awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for the supply of equipment and services related to a FACSAria flow cytometer. The contract has a ceiling value of $33,870.00 and a period of performance ending on November 10, 2012. This order was not set aside for any small business designation. BD Biosciences, a division of the parent...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm-fixed price purchase order contract to Becton, Dickinson And Company (BD) on November 1, 2017 for $162,540.00. The contract is for FACSARIA SERVICE and has an end date of October 31, 2022. BD, a global medical technology company, is providing the government with specialized equipment, reagents, and services related to flow cytometry, cell imaging, and genomics...
- This is a service contract awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health, to Becton, Dickinson and Company (BD) for a BD FACSAria III 4-laser flow cytometry system. The contract has a ceiling value of $128,056.20 and an ultimate completion date of January 31, 2026. It is a firm-fixed price delivery order issued under BD's existing General Services Administration Multiple Award Schedule (MAS) contract. The contract does not...
- Becton, Dickinson and Company, operating through its BDB Division as BD Biosciences, was awarded a delivery order for maintenance services on a FACSCalibur 4 flow cytometer system located at the National Institutes of Health Clinical Center in Bethesda, Maryland. The contract, valued at $14,015.14, was awarded on October 1, 2006, for a one-year period through September 30, 2007. This procurement was conducted as a full and open competition without small business set-aside designation, reflecting...
- This federal contract award to Becton, Dickinson And Company (BD) is a delivery order under the BD Biosciences contract GS24F2044D with the National Human Genome Research Institute, a component of the National Institutes of Health. The contract, with a ceiling value of $9,924.96, is for the supply of a BD FACSCanto flow cytometry system and associated maintenance services from July 1, 2011 to June 30, 2012. The contract is a firm-fixed-price arrangement and does not have a set-aside designation....
- Becton, Dickinson and Company, operating through its BDB Division as BD Biosciences, was awarded a delivery order valued at $11,385 for a one-year maintenance agreement on a FACScan instrument located in Building 10, Room 8B17 at the National Institutes of Health Clinical Center in Bethesda, Maryland. The contract period ran from October 1, 2006, through September 30, 2007, and was awarded without a small business set-aside designation. This delivery order represents a child contract under...
The National Human Genome Research Institute (NHGRI) awarded a $30,193.96 firm fixed-price purchase order to Becton, Dickinson and Company, through its BD Biosciences division, on February 10, 2026, for a one-year maintenance agreement covering a BD FACSAria Fusion flow cytometer system equipped with four lasers and computer workstation. The contract will be performed at the NHGRI facility in Bethesda, Maryland, with an ultimate completion date of January 31, 2027. This purchase order was awarded without a set-aside designation, reflecting BD Biosciences' established competitive position as a large federal contractor specializing in flow cytometry instrumentation and support services. BD Biosciences maintains an extensive federal contract portfolio with the National Institutes of Health and its component institutes, including multiple blanket purchase agreements and indefinite delivery contracts for flow cytometry systems, maintenance services, reagents, and technical support. The maintenance agreement secured under this award represents the company's typical service offerings, which encompass preventive maintenance, corrective repairs, software support, priority response capabilities, and on-site technical assistance. BD's parent company, Becton, Dickinson and Co, operates as a global medical technology manufacturer with diverse divisions serving federal healthcare and research missions across the Department of Veterans Affairs, Defense Health Agency, and other government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.2k | 2/26/26 |